Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01205529 · ClinicalTrials.gov registry record · NA
ST-segment Elevation as an AF Endophenotype
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 161
- Enrollment target
NCT01205529 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 161 participants.
The verdict
NCT01205529, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
Study Summary
The purpose of this study is to look for a similarity in people's genes that may help understand which people could benefit from certain drugs for the treatment of atrial fibrillation (AF).
Interventions
- DRUG Procainamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2010-11 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01205529
The ClinicalTrials.gov registry entry for NCT01205529 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Procainamide is the first listed.
NCT01205529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01205529 about?
NCT01205529 is a clinical study titled "ST-segment Elevation as an AF Endophenotype". The purpose of this study is to look for a similarity in people's genes that may help understand which people could benefit from certain drugs for the treatment of atrial fibrillation (AF).
What is the current status of trial NCT01205529?
This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2010-11. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01205529?
The interventions under investigation include: Procainamide (DRUG).
Who is sponsoring clinical trial NCT01205529?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.